SARS-CoV-2 mRNA – March 2026

• Brand names:
  • Spikevax®
• Pharmaceutical Company:
  • MODERNA AUSTRALIA PTY LTD
• Condition/Indication: Prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
• Meeting Date: March 2026
• Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
• Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)